Credo Diagnostics
Singapore, Singapore· Est.
Fast, affordable point‑of‑care PCR diagnostics for diverse clinical and veterinary applications.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Fast, affordable point‑of‑care PCR diagnostics for diverse clinical and veterinary applications.
Infectious DiseasesRespiratory InfectionsWomen's HealthSexually Transmitted InfectionsVeterinary MedicineGenetic Testing
Technology Platform
Cartridge‑based microfluidic system that automates nucleic acid extraction and real‑time PCR, delivering multiplex results in 20‑40 minutes with integrated data connectivity.
Opportunities
Expansion into US and European point‑of‑care markets, development of multiplex respiratory and STI panels, and leveraging data‑integration services for hospital networks.
Risk Factors
Regulatory clearance for new assays, intense competition from established POCT platforms, and scaling manufacturing to meet global demand.
Competitive Landscape
Competes with Cepheid GeneXpert, Abbott ID NOW, Quidel Sofia, and Roche cobas; differentiates through faster 20‑minute results, low per‑test cost, and a modular cartridge system.